We are learning gradually about the neurologic manifestations during the ongoing coronavirus disease 2019 (COVID)-19 pandemic, a respiratory disease related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). As the clinical evidence is still limited, it makes a sense to critically analyze the spectrum of neurologic involvement caused by SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV), which were causal for epidemics in 2003 and 2012, respectively.